These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 32599890)

  • 1. Endometriosis-Associated Ovarian Cancer: The Origin and Targeted Therapy.
    Murakami K; Kotani Y; Nakai H; Matsumura N
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32599890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RUNX3 is inactivated by promoter hypermethylation in malignant transformation of ovarian endometriosis.
    Guo C; Ren F; Wang D; Li Y; Liu K; Liu S; Chen P
    Oncol Rep; 2014 Dec; 32(6):2580-8. PubMed ID: 25333219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epigenetic inactivation of SPOCK2 in the malignant transformation of ovarian endometriosis].
    Ren F; Wang DB; Li T
    Zhonghua Fu Chan Ke Za Zhi; 2011 Nov; 46(11):822-5. PubMed ID: 22333230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Does Endometriosis Lead to Ovarian Cancer? The Molecular Mechanism of Endometriosis-Associated Ovarian Cancer Development.
    Yachida N; Yoshihara K; Yamaguchi M; Suda K; Tamura R; Enomoto T
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in LINE-1 methylation between endometriotic ovarian cyst and endometriosis-associated ovarian cancer.
    Senthong A; Kitkumthorn N; Rattanatanyong P; Khemapech N; Triratanachart S; Mutirangura A
    Int J Gynecol Cancer; 2014 Jan; 24(1):36-42. PubMed ID: 24304685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.
    Er TK; Su YF; Wu CC; Chen CC; Wang J; Hsieh TH; Herreros-Villanueva M; Chen WT; Chen YT; Liu TC; Chen HS; Tsai EM
    J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of genes associated with stemness and cancer in endometria and endometrioma in a subset of women with endometriosis.
    Ponandai-Srinivasan S; Andersson KL; Nister M; Saare M; Hassan HA; Varghese SJ; Peters M; Salumets A; Gemzell-Danielsson K; Lalitkumar PGL
    Hum Reprod; 2018 Oct; 33(10):1924-1938. PubMed ID: 30020448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare but Still There: A Scoping Review on Endometriosis-Associated Ovarian Cancer.
    Livori K; Calleja-Agius J
    Discov Med; 2024 Mar; 36(182):467-481. PubMed ID: 38531788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometriosis-associated ovarian cancer occurs early during follow-up of endometrial cysts.
    Murakami K; Kotani Y; Shiro R; Takaya H; Nakai H; Matsumura N
    Int J Clin Oncol; 2020 Jan; 25(1):51-58. PubMed ID: 31473885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating modern approaches to pathogenetic concepts of malignant transformation of endometriosis.
    Kobayashi H; Yamada Y; Kawahara N; Ogawa K; Yoshimoto C
    Oncol Rep; 2019 Mar; 41(3):1729-1738. PubMed ID: 30592289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for endometriotic-cyst associated ovarian cancer: A case controlled study.
    Udomsinkul P; Triratanachart S; Oranratanaphan S
    Taiwan J Obstet Gynecol; 2020 Mar; 59(2):269-274. PubMed ID: 32127149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis.
    Chene G; Ouellet V; Rahimi K; Barres V; Provencher D; Mes-Masson AM
    Int J Gynaecol Obstet; 2015 Jul; 130(1):27-30. PubMed ID: 25912412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated RON protein expression in endometriosis and disease-associated ovarian cancers.
    Xu P; Ding S; Zhu L; Le F; Huang X; Tian Y; Zhang X
    Arch Gynecol Obstet; 2017 Mar; 295(3):631-639. PubMed ID: 27888297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyst fluid iron-related compounds as useful markers to distinguish malignant transformation from benign endometriotic cysts.
    Yoshimoto C; Iwabuchi T; Shigetomi H; Kobayashi H
    Cancer Biomark; 2015; 15(4):493-9. PubMed ID: 25835178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathology and ARID1A Expression in Endometriosis- Associated Ovarian Carcinoma (EAOC) Carcinogenesis Model with Endometrial Autoimplantation and DMBA Induction.
    Wuyung PE; Rahadiati FB; Tjahjadi H; Salinah S; Kusmardi K; Kodariah R; Wiweko B
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):553-558. PubMed ID: 33639673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometriosis-associated ovarian cancer: a review of pathogenesis.
    Worley MJ; Welch WR; Berkowitz RS; Ng SW
    Int J Mol Sci; 2013 Mar; 14(3):5367-79. PubMed ID: 23466883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The High Expression of RRM2 Can Predict the Malignant Transformation of Endometriosis.
    Yang B; Wang T; Li N; Zhang W; Hu Y
    Adv Ther; 2021 Oct; 38(10):5178-5190. PubMed ID: 34424503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for the Relationship Between Endometriosis and Epithelial Ovarian Cancer.
    del Carmen MG
    Obstet Gynecol Surv; 2015 Sep; 70(9):587-95. PubMed ID: 26403563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding malignant transformation of endometriosis: imaging features with pathologic correlation.
    Robinson KA; Menias CO; Chen L; Schiappacasse G; Shaaban AM; Caserta MP; Elsayes KM; VanBuren WM; Bolan CW
    Abdom Radiol (NY); 2020 Jun; 45(6):1762-1775. PubMed ID: 30941451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological characteristics, molecular features and novel diagnostic strategies for the detection of malignant transformation of endometriosis (Review).
    Kobayashi H
    Exp Ther Med; 2023 Jun; 25(6):279. PubMed ID: 37206546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.